Ze339
Ze339™ brand herbal extracts are taken from the leaves of a unique variety (Petzell) of the Butterbur (Petasites hybridus) plant. Petzell is grown on GAP-managed farms in Europe. Ze339™ is extracted in a patented process at a pharmaceutical grade facility and is reliably PA safe.
Availability
Ze339™ brand extract is available for the treatment of allergic rhinitis in Switzerland, South Korea, and Brazil. In these countries, tablets containing Ze339™ brand herbal extracts are marketed under the brand name "Tesalin". Ze339™ is marketed in the US as "Zarbee's Naturals Seasonal Relief".
Seasonal Allergic Rhinitis
Ze339™ is indicated for seasonal allergic rhinitis (Hayfever). The ingredient has been evaluated in several placebo-controlled, double-blind clinical studies against prescription and OTC antihistamine medications. Ze339™ was shown to be as effective as the antihistamines cetirizine (Zyrtec) and fexofenadine (Allegra).[1][2] Against desloratadine(Clarinex), an improved version of loratadine(Claritin), Ze339™ had better efficacy in relieving congestion and other allergy symptoms.[3] A graph comparing the ability of Ze339™'s to treat nasal obstruction to that of desloratadine is available within the published article. In these studies, Ze339™ was shown to be less sedating than cetirizine and fexofenadine.[1][2]
Pharmacology
Ze339™ brand extract is not an antihistamine and represents a symptomatic treatment with very different properties.[3] In-vitro studies show that petasins in Ze339™ brand extract inhibit leukotriene biosynthesis and block degranulation in activated mast cells and eosinophils.[4][5]
References
- 1 2 Schapowal, A; Petasites Study, Group (Jan 19, 2002). "Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis.". British Medical Journal 324 (7330): 144–6. doi:10.1136/bmj.324.7330.144. PMC 64514. PMID 11799030.
- 1 2 Schapowal, A; Study, Group (1 June 2005). "Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339". Phytotherapy Research 19 (6): 530–537. doi:10.1002/ptr.1705. PMID 16114089. Retrieved 24 April 2013.
- 1 2 Dumitru, Alina F.; Shamji, Mohamed; Wagenmann, Martin; Hindersin, Simone; Scheckenbach, Kathrin; Greve, Jens; Klenzner, Thomas; Hess, Lorenzo; Nebel, Sabine; Zimmermann, Christian; Zahner, Catherine; Schmidt-Weber, Carsten B.; Chaker, Adam M. "Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine". Journal of Allergy and Clinical Immunology 127 (6): 1515–1521.e6. doi:10.1016/j.jaci.2011.02.045. PMID 21489609.
- ↑ Thomet, O. A. R.; Wiesmann, U. N.; Blaser, K.; Simon, H.-U. (1 August 2001). "Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils". Clinical & Experimental Allergy 31 (8): 1310–1320. doi:10.1046/j.1365-2222.2001.01158.x.
- ↑ Thomet, Olivier A.R; Wiesmann, Ulrich N; Schapowal, Andreas; Bizer, Christian; Simon, Hans-Uwe. "Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus". Biochemical Pharmacology 61 (8): 1041–1047. doi:10.1016/S0006-2952(01)00552-4. PMID 11286996.